Clinical trial
Exploration of Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients With Positive Tumor Budding
NCT07160361 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploration of Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients With Positive Tumor Budding
- Lead sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 1, 2025
- Completion date
- December 31, 2029
- Enrollment
- 56 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.